Multi-agent LLMs for Decision Support in Cervical Cancer During Pregnancy
- Sponsor
- Obstetrics & Gynecology Hospital of Fudan University
- Study ID
- NCT07318701
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- multi-disciplinary agents group — OTHERgenerate diagnosis and treatment opinions for each case from multi-disciplinary agents
- real MDT group — OTHERgenerate diagnosis and treatment opinions for each case from a real MDT team inclduing senior physicians from relevant departments, including gynecologic oncology, pediatrics, obstetrics, medical oncology and radiation oncology.
- junor doctor group — OTHERgenerate diagnosis and treatment opinions for each case from junior doctor who are residents from relevant departments, including gynecologic oncology, pediatrics, obstetrics, medical oncology and radiation oncology.
- junor doctor group with aid of MDT agents — OTHERgenerate diagnosis and treatment opinions for each case from junior doctor who are residents from relevant departments, including gynecologic oncology, pediatrics, obstetrics, medical oncology and radiation oncology after referring to the results from MDT agent .
Study Details
The aim of this study is to develop an AI-assisted decision-making system based on multi-agent large language models and to evaluate its effectiveness and accuracy in the diagnosis and treatment of cervical cancer during pregnancy.
Key Dates
- First listed
- Jan 6, 2026
- Start date
- Jan 1, 2026
- Status verified
- Jan 2026
- Primary completion
- Jun 30, 2026
- Completion
- Oct 30, 2026
Study Design
- Enrollment
- 150 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Arm1: multi-disciplinary agents groupgenerate diagnosis and treatment opinions from multi-disciplinary agents
- Placebo Comparator: Arm2: real MDT group/ junior doctors group/junior doctors after referring to agent results groupgenerate diagnosis and treatment opinions from real MDT group/ junior doctors group/junior doctors after referring to agent results group
Primary Outcome Measure
Accuracy of the MDT decision [ Time Frame: immediately after the intervention ]
Central Contacts
- Keqin Hua, Doctor+86-021-33189900
Find similar trials
Related Studies
- Specimen and Data Study for Ovarian Cancer Early Detection and PreventionRecruiting · Northwestern University · Chicago, Illinois
- Cervical Cancer Detection Using Optical SpectroscopyRecruiting · Duke University · Durham, North Carolina
- Image-Guided Gynecologic BrachytherapyRecruiting · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Baltimore, Maryland
- FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing SurgeryRecruiting · University Health Network, Toronto · Houston, Texas